Analysts have given Moderna a total of 6 ratings, with the consensus rating being Neutral. The average one-year price target ...

A rally in big tech drove stocks higher, but the market came well off session highs as traders geared up for Friday’s key jobs report. Bond yields fell. The dollar wavered.

A rally in big tech drove stocks higher, with traders parsing the latest inflation and spending data illustrating the tug and ...

Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.07 per share a year ago. These ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

Biotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

NEW YORK, NY / ACCESS Newswire / July 28, 2025 / For decades, sustainability markets operated like closed clubs-built by ...

NEW YORK, NY / ACCESS Newswire / July 29, 2025 / Europe is reaching a pivotal moment in its industrial transformation. And ...

TORONTO, ON / ACCESS Newswire / July 29, 2025 / Highlander Silver Corp. (TSX:HSLV) (“Highlander Silver” or the “Company“) is ...

The SPDR® S&P Biotech ETF rebounded over 20% since lows in April, despite changes at the FDA that could have signaled a ...

Evaluate the expected performance of Moderna (MRNA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for ...